To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts. BCG’s 6P framework can help leaders understand the full scope of the undertaking and focus on the top priorities as they pursue the medtech GenAI imperative.
◈ Policy, Platform, and Partnership issues require thoughtful planning and execution, taking into account the ethical and data-privacy concerns unique to health care.
◈ People and Processes needed to kick-start and operate GenAI solutions at scale are not necessarily medtech-specific, but the change management implications are no less for it.
◈ The Potential for GenAI in medtech was described in “Medtech’s Generative AI Opportunity.” The remaining Ps will be covered in detail in three upcoming BCG publications.
The opportunity for better outcomes, increased efficiency, and greater value creation makes GenAI the new medtech imperative.
